Stay updated on Immunotherapy Combinations in Solid Cancers Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combinations in Solid Cancers Clinical Trial page.
Latest updates to the Immunotherapy Combinations in Solid Cancers Clinical Trial page
- Check3 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.4%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the study's location.SummaryDifference4%
- Check53 days agoChange DetectedSeveral links related to clinical trials and specific drugs have been removed, indicating a potential shift in focus or available information on the website.SummaryDifference7%
- Check67 days agoChange DetectedThe website has been updated to Revision v2.12.2, adding new links for clinical trials related to Ipilimumab, Nivolumab, and Relatlimab, along with additional data fields for study information.SummaryDifference7%
- Check75 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.1%
Stay in the know with updates to Immunotherapy Combinations in Solid Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combinations in Solid Cancers Clinical Trial page.